tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:6855 Stock Latest News

Ascentage Pharma Reports Revenue Decline Amidst Strategic Drug Approvals
Company AnnouncementsAscentage Pharma Reports Revenue Decline Amidst Strategic Drug Approvals
1M ago
6855
Ascentage Pharma receives clearance from U.S. FDA, EMA to conduct GLORA-4
PremiumThe Fly
Ascentage Pharma receives clearance from U.S. FDA, EMA to conduct GLORA-4
1M ago
AAPG
Ascentage Pharma’s Lisaftoclax Phase III Trial for HR-MDS Cleared by FDA and EMA
PremiumCompany Announcements
Ascentage Pharma’s Lisaftoclax Phase III Trial for HR-MDS Cleared by FDA and EMA
1M ago
6855
Ascentage Pharma Schedules Board Meeting to Review Interim Results
PremiumCompany Announcements
Ascentage Pharma Schedules Board Meeting to Review Interim Results
2M ago
6855
Ascentage Pharma Completes Share Placement and Subscription, Raising HK$1.49 Billion
PremiumCompany Announcements
Ascentage Pharma Completes Share Placement and Subscription, Raising HK$1.49 Billion
2M ago
6855
Ascentage Pharma Announces Share Placing and Subscription to Raise HK$1.5 Billion
PremiumCompany AnnouncementsAscentage Pharma Announces Share Placing and Subscription to Raise HK$1.5 Billion
2M ago
6855
Ascentage Pharma announces China NMPA approval of lisaftoclax
Premium
The Fly
Ascentage Pharma announces China NMPA approval of lisaftoclax
3M ago
AAPG
Ascentage Pharma’s Lisaftoclax Gains Approval for CLL/SLL Treatment in China
Premium
Company Announcements
Ascentage Pharma’s Lisaftoclax Gains Approval for CLL/SLL Treatment in China
3M ago
6855
Ascentage Pharma names Dr. Veet Misra as CFO
PremiumThe Fly
Ascentage Pharma names Dr. Veet Misra as CFO
3M ago
AAPG
Ascentage Pharma Grants Further RSUs to Employees Under 2021 Scheme
PremiumCompany Announcements
Ascentage Pharma Grants Further RSUs to Employees Under 2021 Scheme
3M ago
6855
Ascentage Pharma Reports Promising Study Results at EHA 2025
PremiumCompany Announcements
Ascentage Pharma Reports Promising Study Results at EHA 2025
3M ago
6855
Ascentage Pharma Unveils Promising Clinical Data at ASCO 2025
PremiumCompany Announcements
Ascentage Pharma Unveils Promising Clinical Data at ASCO 2025
4M ago
6855
Ascentage Pharma Successfully Passes All AGM Resolutions
PremiumCompany AnnouncementsAscentage Pharma Successfully Passes All AGM Resolutions
4M ago
6855
Ascentage Pharma Announces Supplemental AGM Notice with Key Resolutions
Premium
Company Announcements
Ascentage Pharma Announces Supplemental AGM Notice with Key Resolutions
5M ago
6855
Ascentage Pharma Unveils Promising Preclinical Results at AACR 2025
Premium
Company Announcements
Ascentage Pharma Unveils Promising Preclinical Results at AACR 2025
5M ago
6855
Ascentage Pharma presents results from five preclinical studies at AACR meeting
PremiumThe Fly
Ascentage Pharma presents results from five preclinical studies at AACR meeting
5M ago
AAPG
Ascentage Pharma to Present Key Clinical Study Data at 2025 ASCO Meeting
PremiumCompany Announcements
Ascentage Pharma to Present Key Clinical Study Data at 2025 ASCO Meeting
5M ago
6855
Ascentage Pharma’s Drugs Gain Recognition in CSCO 2025 Guidelines
PremiumCompany Announcements
Ascentage Pharma’s Drugs Gain Recognition in CSCO 2025 Guidelines
5M ago
6855
Ascentage announces inclusion of Lisaftoclax, Olverembatinib in CSCO guidelines
PremiumThe Fly
Ascentage announces inclusion of Lisaftoclax, Olverembatinib in CSCO guidelines
5M ago
AAPG
Ascentage Pharma Announces 2025 AGM with Key Resolutions
PremiumCompany AnnouncementsAscentage Pharma Announces 2025 AGM with Key Resolutions
5M ago
6855
Ascentage Pharma Advances 2022 RSU Scheme with Share Purchase
Premium
Company Announcements
Ascentage Pharma Advances 2022 RSU Scheme with Share Purchase
6M ago
6855
Ascentage Pharma Advances 2022 RSU Scheme with Share Purchase
Premium
Company Announcements
Ascentage Pharma Advances 2022 RSU Scheme with Share Purchase
6M ago
6855

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >